Peritonitis Clinical Trial
Official title:
Descriptive and Correlational Study of the Epidemiological, Clinical and Etiological Characteristics of Peritonitis in the Surgical Department of the State University Hospital of Haiti During the Period From January 2013 to December 2018
NCT number | NCT04182217 |
Other study ID # | 01 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | September 10, 2018 |
Est. completion date | October 1, 2019 |
Verified date | February 2020 |
Source | Universite d'Etat d'Haiti |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The primary objective:
To study the prevalence, etiology, and factors associated with the severity of peritonitis
and its complications in the surgery department of the State University Hospital of Haiti.
Secondary objectives:
- Identify epidemiological characteristics.
- Describe the main etiologies encountered in the service
- Measure the time required for treatment and its consequences on the evolution of
peritonitis.
Status | Completed |
Enrollment | 91 |
Est. completion date | October 1, 2019 |
Est. primary completion date | March 20, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 11 Years to 82 Years |
Eligibility |
Inclusion Criteria: Patients whose peritonitis diagnosis was made and operated on in the department during the period. Patient whose record is identified (with age, sex) with at least the clinical and etiological diagnosis identified in the operating protocol. Exclusion Criteria: Patients with incomplete records. Cases of post-operative peritonitis. Patient under 10 years of age |
Country | Name | City | State |
---|---|---|---|
Haiti | Axler JEAN PAUL | Port-au-Prince | Ouest |
Lead Sponsor | Collaborator |
---|---|
Universite d'Etat d'Haiti |
Haiti,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Heart Rate | Heart rate number of beats/min reported in the file entry for each patients | immediately after admission, up to 30 minutes | |
Primary | Respiratory Rate | Respiratory rate number of cycle/min reported in the file of entry | immediately after admission, up to 30 minutes | |
Primary | Temperature | Temperature in celsius reported in the file of entry | immediately after admission, up to 30 minutes | |
Primary | Blood Pressure | Systolic Blood pressure in mmHg reported in the file of entry | immediately after admission, up to 30 minutes | |
Primary | Etiological Diagnosis | final diagnosis retained in the operating protocol | immediately post-surgery | |
Primary | Demographic Parameters | Age in years described in the admission file | during admission | |
Secondary | Onset of Symptoms | Days before coming at the hospital | immediately after admission | |
Secondary | Delay in Pre-op | the pre-operative time in days which describes the time between the date of the intervention and the date of admission | immediately post-surgery | |
Secondary | Delay in Post-op | the time in days between the date of the intervention and the leaving of the patient at the hospital | immediately after hospitalization | |
Secondary | Delay in Hospital | the time in days between the date of admission and the date of leaving the hospital | immediately after hospitalization |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04070196 -
Point-of-care Test for Diagnosis of Peritonitis in Peritoneal Dialysis Patients
|
N/A | |
Completed |
NCT00657566 -
SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection
|
Phase 3 | |
Recruiting |
NCT00131196 -
Functional Genomic Influences on Disease Progression and Outcome in Sepsis
|
N/A | |
Completed |
NCT00195351 -
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection
|
Phase 4 | |
Recruiting |
NCT03310606 -
Serum and Peritoneal Concentration in Antibiotics During the Surgical Management of Peritonitis
|
N/A | |
Completed |
NCT01222663 -
Effects of Hemoperfusion With a Polymyxin B Membrane in Peritonitis With Septic Shock
|
Phase 3 | |
Completed |
NCT00230971 -
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
|
Phase 4 | |
Recruiting |
NCT03790176 -
ZAVI APD ELF Protocol v2.2
|
Phase 1 | |
Completed |
NCT03668197 -
Children Peritonitis Ecology at CHU de Rennes - (IIAPEDIA)
|
||
Recruiting |
NCT01837342 -
Multicenter Study Comparing Morbidity and Quality of Life Associated in the Treatment by Surgical Resection and the Conservative Treatment, After Favorable Evolution of Purulent Peritonitis That Originates From Diverticulitis Treated by Mini-invasive Surgery
|
N/A | |
Completed |
NCT00497744 -
A Pharmacokinetic Study of Cefepime After Administration Into Dialysate in Patients With Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis
|
N/A | |
Recruiting |
NCT03334006 -
Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis (PEPPER Trial).
|
Phase 2 | |
Terminated |
NCT03403751 -
Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury
|
Phase 3 | |
Withdrawn |
NCT00463762 -
Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.
|
Phase 4 | |
Active, not recruiting |
NCT02755610 -
Check List to Improve Patient Self-care and Product Defect Report in Continuous Ambulatory Peritoneal Dialysis
|
N/A | |
Not yet recruiting |
NCT05308849 -
Peritoneal Diffusion and Efficacy of Antibiotic Therapy in Pediatric Peritonitis
|
N/A | |
Completed |
NCT02726932 -
Intra-abdominal View and Inflammatory Markers in Secondary Peritonitis - Correlation to Recovery
|
||
Recruiting |
NCT05050253 -
Lavage With Super-Oxidized Solution for Secondary Peritonitis
|
N/A | |
Completed |
NCT02926846 -
IV Antibiotics With Lavage for Severe PD Peritonitis
|
Phase 4 | |
Completed |
NCT01793688 -
Drug Use Investigation Of Sulbactam/Ampicillin (UNASYN) 12g (Regulatory Post Marketing Commitment Plan)
|
N/A |